Cytokinetics

CYTK • NASDAQ • Stock Fundamentals

Cytokinetics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert I. Blum, with a market cap of $10.4B.

Market Cap$10.4B

Employees564.0

CEORobert I. Blum

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 21 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Cytokinetics

Cytokinetics (CYTK) has a market capitalization of $10.4B and trades on NASDAQ.

Cytokinetics has approximately 564 employees.